TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Glucose-stimulated insulin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: More than 50% improvement in POM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician and patient global assessment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: CA9 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: cumulative failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Acuity (VA) improvement or stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve of sensory block levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum sensory block levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in mild-to-moderate AV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage decrease in MAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores over 120 minutes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total opioid dose
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Need for additional opioid doses
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Lower limb artery intima-media thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Artery plaque area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Concentrations of serum TC and LDL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean PASI improvement from study baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total GI symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Impairment of Activities of Daily Living (ADLs)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mean alveolar concentration of sevoflurane
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Voice Handicap Index (VHI) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent jitter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Noise-to-harmonics ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite primary end point of death, myocardial infarction (MI), or refractory ischemia
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of myocardial infarction (MI) or death
Endpoint domain: Mortality/survival
Primary endpoint: Quality of life (OSA-18 survey)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decision process appraisal
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: CSA of the levator ani muscle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma ammonia concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma glutamate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Alpha coefficient of the QT-R-R relationship
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: thrombotic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: First attempt success rate of pulse detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pulse detection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Confidence levels in using ultrasound for pulse detection
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Slower progression of myocardial fibrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total number of intradialytic hypotensive episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: survival advantage of complete lymph-node dissection
Endpoint domain: Mortality/survival
Primary endpoint: Total creatine (TCr)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Bench-press strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Whole-body lean tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean peak anti-Xa level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean trough anti-Xa level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tummy time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unrestrained floor time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EULAR moderate to good responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in synovial mRNA expression of MMP-1 and MMP-3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in plasma CXCL10
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: craving response to marijuana cues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower total error counts of a cognitive test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Greater levels of subjective relaxation, comfort, and healing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Lower levels of waveform index‐1 assessed via accelerated plethysmography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall incidence rate
Endpoint domain: Mortality/survival
Primary endpoint: Physical performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to full recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Collagen content of the left upper arm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hamstring re-injury rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Efficacy and safety of insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CFU/ml in carious dentin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Breakthrough bleeding/spotting (BTB/S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Knowledge about breast cancer treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Perceived barriers to mammography
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean subjective scan quality
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage decrements in mean power output
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Venham score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Reduction in retinal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical Global Impression‐Improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of subjects achieving Hb response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to achieve Hb response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Week 20 virologic response (W20 VR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Sustained virologic response (SVR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cervical dilation of at least 8 mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reversal of anticoagulant effects of heparin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious side effects
Endpoint domain: Adverse events/effects
Primary endpoint: Performance on the adaptive tracker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Memory performance on the VVLT-15
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in global HRQL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in SGRQ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal epithelial disruption rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients reporting any adverse event within 48 hours
Endpoint domain: Adverse events/effects
Primary endpoint: Bone maturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Berg Balance score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of posttraumatic infections
Endpoint domain: Adverse events/effects
Primary endpoint: Prolongation of S-T segment depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Duration of effort
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: increase in diet adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alanine aminotransferase normalisation plus HBV DNA <3400 IU/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: HBV DNA <2000 IU/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: HBsAg clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: urine cotinine concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reported child SHSe in the number of cigarettes exposed per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: latency of movement-related brain macropotentials
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: RMSSD change from baseline to 4 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Power spectrum in LF band change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: respiratory minute volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Implementation of nutrition and physical activity policy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HF awareness scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-care knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: disability indices
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: neck strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Sensitivity of 99mTc‐L,L‐EC scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Specificity of 99mTc‐L,L‐EC scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Inter-observer variability for 99mTc‐L,L‐EC scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Intraoperative complication rates
Endpoint domain: Adverse events/effects
Primary endpoint: Adequate bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitality score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total protein deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total lysozyme deposition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CHEOPS value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first analgesic need
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total amount of analgesic need
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSA slope during followup
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PSADT (Prostate-Specific Antigen Doubling Time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Varix thrombosis after 30 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Total flow reduction in the treated vessel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Incidence of hypotensive systolic blood pressure episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total narcotics use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neonatal hematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: lumen area gain compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Clinical breast examination rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total time taken to complete the evaluation task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: errors during the task
Endpoint domain: Adverse events/effects
Primary endpoint: Treatment success defined as >=3 spontaneous BMs per week with no fecal soiling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance on the Digit Symbol Substitution test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Immediate and delayed explicit recall
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delta of serum PTH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: delta values of serum 25(OH)D3
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: delta values of serum FGF23
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Likelihood of Acute Coronary Syndrome (ACS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: cyst volume reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for massive perioperative transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Leukocyte concentration of vitamin C
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DBP and SBP values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Intensity of hematologic toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Objective remission rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: in-stent late loss at nine months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: minutes of moderate to vigorous physical activity (MVPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin side effects
Endpoint domain: Adverse events/effects
Primary endpoint: post-treatment symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-treatment residual urine volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Duration of Exclusive Breastfeeding (EBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ITN use among children <5 years old
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adjusted mortality
Endpoint domain: Mortality/survival
Primary endpoint: onset of pain relief within 30 minutes postdose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: no or mild headache 2 hours postdose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: return to usual activities within 2 hours postdose
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Onset of block time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time until 10% recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrent HF hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Development of seromas
Endpoint domain: Adverse events/effects
Primary endpoint: Thrombosis of the stent
Endpoint domain: Adverse events/effects
Primary endpoint: Failure to complete therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of emesis in the first 24 hours after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Cooperation and sedation in the PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proprioception accuracy of the knee joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SPV (Stroke Volume Variation)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deltadown
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of EUS in assessing recurrent rectal cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preparation of questions for doctor
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Expression of top concerns at the beginning of the visit
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Satisfaction with care
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean peak pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in dentine hypersensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite endpoint of death or MI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Frequency of acute and chronic rejection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Objective cure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total translations of cups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total rotations of cups
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: periprosthetic BMD at medial side of the stem
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median decrease in viral load (VL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of vasomotor symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in yellowness (delta b*)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deterioration rate of untreated childhood IXT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: initiation of therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baseline temperatures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe HIE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: reduced synovitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blush grade improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Efficacy on certain blood factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: All-cause mortality at 180 days
Endpoint domain: Mortality/survival
Primary endpoint: Motor slowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Attention span
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Intent to quit smoking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ADAS-cog score variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 5-km TT performance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28-day mortality risk
Endpoint domain: Mortality/survival
Primary endpoint: Moderate to severe lymphedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of cutaneous sensory blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motivation for therapy
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: OHIPG‐14 total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: XQ Part 1 dysphagia score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GMC antibody concentrations (µg/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes